Product Description
Mechanisms of Action: CaSR Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: GSK
Company Location: Europe
Company CEO: Emma Walmsley
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Other|Osteoporosis
Phase 1: Osteoporosis|Stem Cell Transplant|Bone Marrow Transplantation
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01802892 |
Ronacaleret | P1 |
Completed |
Stem Cell Transplant |
2013-04-02 |
2019-03-19 |
Treatments |
|
NCT01466335 |
NCT01466335 | P1 |
Completed |
Stem Cell Transplant|Bone Marrow Transplantation |
2012-03-05 |
2019-03-19 |
Treatments |
|
NCT00532077 |
CR9108122 | P1 |
Completed |
Osteoporosis |
2008-01-01 |
2019-03-21 |
Treatments |
|
NCT00508534 |
CR9106339 | P1 |
Completed |
Osteoporosis |
2007-08-01 |
2019-03-21 |
Treatments |
|
NCT00468689 |
CR9107262 | P1 |
Completed |
Osteoporosis |
2007-08-01 |
2019-03-21 |
Treatments |
|
NCT00499928 |
CR9106327 | P1 |
Completed |
Osteoporosis |
2007-07-01 |
2019-03-21 |
Treatments |
|
NCT00388596 |
CR9108985 | P1 |
Completed |
Osteoporosis |
None |
2019-03-21 |
Treatments |
|
NCT00554255 |
NCT00554255 | P1 |
Completed |
Osteoporosis |
None |
2019-03-22 |
Treatments |
|
NCT00540878 |
CR9108307 | P1 |
Completed |
Osteoporosis |
None |
2019-03-21 |
Treatments |
|
NCT00651534 |
CR9106341 | P1 |
Completed |
Osteoporosis |
None |
2019-03-18 |
Treatments |
|
2007-001477-29 |
2007-001477-29 | P2 |
Terminated |
Unknown |
2009-01-10 |
2022-03-12 |
Treatments |
|
NCT00471237 |
Study CR9108963 | P2 |
Terminated |
Osteoporosis |
2008-12-26 |
2025-02-07 |
||
2006-006015-72 |
2006-006015-72 | P2 |
Terminated |
Osteoporosis |
2008-12-18 |
2022-03-12 |
Treatments |
|
NCT00548496 |
CR9108914 | P2 |
Terminated |
Other |
2008-11-26 |
2019-03-22 |
Recent News Events
Date |
Type |
Title |
|---|